177 related articles for article (PubMed ID: 29670842)
21. Optimization of paclitaxel-loaded poly (d,l-lactide-co-glycolide-N-p-maleimido benzoic hydrazide) nanoparticles size using artificial neural networks.
Mostafavi SH; Aghajani M; Amani A; Darvishi B; Noori Koopaei M; Pashazadeh AM; Maghazei MS; Alvandifar F; Nabipour I; Karami F; Assadi M; Dinarvand R
Pharm Dev Technol; 2015 Nov; 20(7):845-853. PubMed ID: 24980221
[TBL] [Abstract][Full Text] [Related]
22. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
23. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma.
Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P
J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944
[TBL] [Abstract][Full Text] [Related]
24. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
25. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
Budhian A; Siegel SJ; Winey KI
Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
[TBL] [Abstract][Full Text] [Related]
26. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
Diab T; Alkafaas SS; Shalaby TI; Hessien M
Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
[TBL] [Abstract][Full Text] [Related]
29. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
30. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
Fonseca C; Simões S; Gaspar R
J Control Release; 2002 Oct; 83(2):273-286. PubMed ID: 12363453
[TBL] [Abstract][Full Text] [Related]
33. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
Song X; Zhao Y; Wu W; Bi Y; Cai Z; Chen Q; Li Y; Hou S
Int J Pharm; 2008 Feb; 350(1-2):320-9. PubMed ID: 17913411
[TBL] [Abstract][Full Text] [Related]
34. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
[TBL] [Abstract][Full Text] [Related]
35. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
[TBL] [Abstract][Full Text] [Related]
36. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H
Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868
[TBL] [Abstract][Full Text] [Related]
37. Effect of polymeric stabilizers on the size and stability of PLGA paclitaxel nanoparticles.
Sakhi M; Khan A; Khan I; Ahmad Khan S; Irum Khan S; Ali Khattak M; Uddin MN; Kazi M; Nasir F
Saudi Pharm J; 2023 Sep; 31(9):101697. PubMed ID: 37559864
[TBL] [Abstract][Full Text] [Related]
38. Enzymatic protection and biocompatibility screening of enzyme-loaded polymeric nanoparticles for neurotherapeutic applications.
Liao R; Pon J; Chungyoun M; Nance E
Biomaterials; 2020 Oct; 257():120238. PubMed ID: 32738657
[TBL] [Abstract][Full Text] [Related]
39. Preparation and biodegradable properties of hydroxyapatite nanoparticle composite coated with poly lactic-co-glycolic acid/polyvinyl alcohol for bone regeneration.
Istikharoh F; Sujuti H; Mustamsir E; Swastirani A
Dent Med Probl; 2020; 57(4):363-367. PubMed ID: 33448162
[TBL] [Abstract][Full Text] [Related]
40. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.
Cerqueira BBS; Lasham A; Shelling AN; Al-Kassas R
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():593-600. PubMed ID: 28482569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
